In vitro cytotoxicity of surface modified bismuth nanoparticles

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 10, 2012, Pages 2563-2573

  Luo, Yang ^a,b   Wang, Chaoming ^a,c   Qiao, Yong ^a   Hossain, Mainul ^a,c   Ma, Liyuan ^a   Su, Ming ^a,c  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c University of Central Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH NANOPARTICLES; CELL VIABILITY; CELLULAR MEMBRANES; CONCENTRATION-DEPENDENT; HELA CELL; HIGH CONCENTRATION; IN-VITRO; METABOLIC FUNCTION; SIMULTANEOUS USE; SURFACE-MODIFIED; TOXICITY ASSAYS;

BIOLOGICAL MATERIALS; BISMUTH; BISMUTH COMPOUNDS; CELL MEMBRANES; CYTOLOGY; CYTOTOXICITY; ORGANIC COMPOUNDS; POLYETHYLENE GLYCOLS; SILICA; TOXICITY;

NANOPARTICLES;

AMINE; BISMUTH; CALCEIN; CALCEIN ACETOXYMETHYL ESTER; ETHIDIUM HOMODIMER 1; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HOMODIMER; IRON OXIDE; MACROGOL; NANOCOATING; NANOPARTICLE; NITROBLUE TETRAZOLIUM; SILICON DIOXIDE; UNCLASSIFIED DRUG;

CELL VIABILITY; CONFERENCE PAPER; CYTOTOXICITY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; PRIORITY JOURNAL; SYNTHESIS; X RAY DIFFRACTION; X RAY PHOTOELECTRON SPECTROSCOPY;

BISMUTH; CELL SURVIVAL; FLUORESCEINS; GLUCOSEPHOSPHATE DEHYDROGENASE; HELA CELLS; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; PHOTOELECTRON SPECTROSCOPY; SURFACE PROPERTIES; X-RAY DIFFRACTION;

EID: 84867365262     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4716-1     Document Type: Conference Paper

References (50)

1. Pamphlett R, Danscher G, Rungby J, Stoltenberg M. Tissue uptake of bismuth from shotgun pellets. Environ Res. 2000;82:258-62.
2. Larsen A, Martiny M, Stoltenberg M, Danscher G, Rungby J. Gastrointestinal and systemic uptake of bismuth in mice after oral exposure. Pharmacol Toxicol. 2003;93:82-90.
3. Andrews PC, Ferrero RL, Forsyth CM, Junk PC, Maclellan JG, Peiris RM. Bismuth (III) saccharinate and thiosaccharinate complexes and the effect of ligand substitution on their activity against Helicobacter pylori. Organometallics. 2011;30:6283-91.
4. Gisbert JP. Helicobacter pylori eradication: a new, single-capsule bismuth-containing quadruple therapy. Nat Rev Gastroenterol Hepatol. 2011;8:307-9.
5. Malfertheiner P, Bazzoli F, Delchier JC, Celinski K, Giguere M, Riviere M, et al. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. Lancet. 2011;377:905-13.
6. Rosenblat TL, McDevitt MR, Mulford DA, Pandit-Taskar N, Divgi CR, Panageas KS, et al. Sequential cytarabine and alphaparticle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia. Clin Cancer Res. 2010;16:5303-11.
7. Leussink BT, Baelde HJ, Broekhuizen-van den Berg TM, de Heer E, van der Voet GB, Slikkerveer A, et al. Renal epithelial gene expression profile and bismuth-induced resistance against cisplatin nephrotoxicity. Hum Exp Toxicol. 2003;22:535-40.
8. Larsen A, Stoltenberg M, West MJ, Danscher G. Influence of bismuth on the number of neurons in cerebellum and hippocampus of normal and hypoxia-exposed mouse brain: a stereological study. J Appl Toxicol. 2005;25:383-92.
9. Geyikoglu F, Turkez H. Genotoxicity and oxidative stress induced by some bismuth compounds in human blood cells in vitro. Fresenius Environ Bull. 2005;14:854-60.
10. Stoltenberg M, Larsen A, Zhao M, Danscher G, Brunk UT. Bismuth-induced lysosomal rupture in J774 cells. APMIS. 2002;110:396-402.
11. Turkez H, Geyikoglu F, Keles MS. Biochemical response to colloidal bismuth subcitrate-dose-time effect. Biol Trace Elem Res. 2005;105:151-8.
12. Stoltenberg M, Hogenhuis JA, Hauw JJ, Danscher G. Autometallographic tracing of bismuth in human brain autopsies. J Neuropathol Exp Neurol. 2001;60:705-10.
13. Kinsella JM, Jimenez RE, Karmali PP, Rush AM, Kotamraju VR, Gianneschi NC, et al. X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew Chem Int Ed. 2011;50:12308-11.
14. Rabin O, Manuel Perez J, Grimm J, Wojtkiewicz G, Weissleder R. An X-ray computed tomography imaging agent based on longcirculating bismuth sulphide nanoparticles. Nat Mater. 2006;5:118-22.
15. Ding SN, Shan D, Xue HG, Cosnier S. A promising biosensingplatform based on bismuth oxide polycrystalline-modified electrode: characterization and its application in development of amperometric glucose sensor. Bioelectrochemistry. 2010;79:218-22.
16. Ma L, Hong Y, Ma Z, Kaittanis C, Perez JM, Su M. Multiplexed highly sensitive detections of cancer biomarkers in thermal space using encapsulated phase change nanoparticles. Appl Phys Lett. 2009;95:043701.
17. Wang C, Sun Z, Ma L, Su M. Simultaneous detection of multiple biomarkers with over three orders of concentration difference using phase change nanoparticles. Anal Chem. 2011;83:2215-9.
18. Hossain M, Wang C, Su M. Multiplexed biomarker detection using X-ray fluorescence of composition-encoded nanoparticles. Appl Phys Lett. 2010;97:263704.
19. Wang L, Nagesha DK, Selvarasah S, Dokmeci MR, Carrier RL. Toxicity of CdSe nanoparticles in Caco-2 cell cultures. J Nanobiotechnol. 2008;6:11.
20. Zhao J, Castranova V. Toxicology of nanomaterials used in nanomedicine. J Toxicol Environ Health B Crit Rev. 2011;14:593-632.
21. Zhang Y, Yu W, Jiang X, Lv K, Sun S, Zhang F. Analysis of the cytotoxicity of differentially sized titanium dioxide nanoparticles in murine MC3T3-E1 preosteoblasts. J Mater Sci Mater Med. 2011;22:1933-45.
22. Clift MJ, Rothen-Rutishauser B, Brown DM, Duffin R, Donaldson K, Proudfoot L, et al. The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. Toxicol Appl Pharmacol. 2008;232:418-27.
23. Zhu ZJ, Carboni R, Quercio MJ Jr, Yan B, Miranda OR, Anderton DL, et al. Surface properties dictate uptake, distribution, excretion, and toxicity of nanoparticles in fish. Small. 2010;6:2261-5.
24. Hoshino A, Hanada S, Yamamoto K. Toxicity of nanocrystal quantum dots: the relevance of surface modifications. Arch Toxicol. 2011;85:707-20.
25. Selim KK, Xing ZC, Choi MJ, Chang Y, Guo H, Kang IK. Reduced cytotoxicity of insulin-immobilized CdS quantum dots using PEG as a spacer. Nanoscale Res Lett. 2011;6:528.
26. Zhang XD, Wu D, Shen X, Liu PX, Yang N, Zhao B, et al. Sizedependent in vivo toxicity of PEG-coated gold nanoparticles. Int J Nanomed. 2011;6:2071-81.
27. Cho WS, Cho MJ, Jeong J, Choi M, Cho HY, Han BS, et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol. 2009;236:16-24
28. Malugin A, Ghandehari H. Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J Appl Toxicol. 2010;30:212-7.
29. Nair S, Sasidharan A, Divya Rani VV, Menon D, Manzoor K, Raina S. Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J Mater Sci Mater Med. 2009;20(Suppl 1):S235-41.
30. Wang H, Wingett D, Engelhard MH, Feris K, Reddy KM, Turner P, et al. Fluorescent dye encapsulated ZnO particles with cellspecific toxicity for potential use in biomedical applications. J Mater Sci Mater Med. 2009;20:11-22.
31. 2+-induced hepatic L02 cells toxicity. J Environ Sci (China). 2010;22:1987-92.
32. Mahmoudi M, Simchi A, Imani M, Milani AS, Stroeve P. An in vitro study of bare and poly (ethylene glycol)-co-fumarate-coated superparamagnetic iron oxide nanoparticles: a new toxicity identification procedure. Nanotechnology. 2009;20:225104.
33. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol. 2010;40:328-46.
34. Yan M, Zhang Y, Xu K, Fu T, Qin H, Zheng X. An in vitro study of vascular endothelial toxicity of CdTe quantum dots. Toxicology. 2011;282:94-103.
35. von Recklinghausen U, Hartmann LM, Rabieh S, Hippler J, Hirner AV, Rettenmeier AW, et al. Methylated bismuth, but not bismuth citrate or bismuth glutathione, induces cyto-and genotoxic effects in human cells in vitro. Chem Res Toxicol. 2008;21:1219-28.
36. Talapin DV, Rogach AL, Kornowski A, Haase M, Weller H. Highly luminescent monodisperse CdSe and CdSe/ZnS nanocrystals synthesized in a hexadecylamine-trioctylphosphine oxide-trioctylphospine mixture. Nano Lett. 2001;1:207-11.
37. Kirchner C, Liedl T, Kudera S, Pellegrino T, Munoz Javier A, Gaub HE, et al. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett. 2005;5:331-8.
38. Navarro E, Piccapietra F, Wagner B, Marconi F, Kaegi R, Odzak N, et al. Toxicity of silver nanoparticles to chlamydomonas reinhardtii. Environ Sci Technol. 2008;42:8959-64.
39. Griffitt RJ, Weil R, Hyndman KA, Denslow ND, Powers K, Taylor D, et al. Exposure to copper nanoparticles causes gill injury and acute lethality in zebrafish (Danio rerio). Environ Sci Technol. 2007;41:8178-86.
40. Pittella F, Zhang M, Lee Y, Kim HJ, Tockary T, Osada K, et al. Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block chargeconversional polymer for efficient gene knockdown with negligible cytotoxicity. Biomaterials. 2011;32:3106-14.
41. Tiwari DK, Jin T, Behari J. Bio-distribution and toxicity assessment of intravenously injected anti-HER2 antibody conjugated CdSe/ZnS quantum dots in Wistar rats. Int J Nanomed. 2011;6:463-75.
42. Naqvi S, Samim M, Abdin M, Ahmed FJ, Maitra A, Prashant C, et al. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int J Nanomed. 2010;5:983-9.
43. Mahmoudi M, Simchi A, Milani AS, Stroeve P. Cell toxicity of superparamagnetic iron oxide nanoparticles. J Colloid Interface Sci. 2009;336:510-8.
44. Gupta AK, Berry C, Gupta M, Curtis A. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis. IEEE Trans Nanobiosci. 2003;2:255-61.
45. Park J, Fong PM, Lu J, Russell KS, Booth CJ, Saltzman WM, et al. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. Nanomedicine. 2009;5:410-8.
46. Liu Y, Shipton MK, Ryan J, Kaufman ED, Franzen S, Feldheim DL. Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly (ethylene glycol) monolayers. Anal Chem. 2007;79:2221-9.
47. Baber O, Jang M, Barber D, Powers K. Amorphous silica coatings on magnetic nanoparticles enhance stability and reduce toxicity to in vitro BEAS-2B cells. Inhal Toxicol. 2011;23:532-43.
48. Serfontein WJ, Mekel R. Bismuth toxicity in man II. Review of bismuth blood and urine levels in patients after administration of therapeutic bismuth formulations in relation to the problem of bismuth toxicity in man. Res Commun Chem Pathol Pharmacol. 1979;26:391-411.
49. Arata T, Oyama Y, Tabaru K, Satoh M, Hayashi H, Ishida S, et al. Cytotoxic effects of triphenylbismuth on rat thymocytes: comparisons with bismuth chloride and triphenyltin chloride. Environ Toxicol. 2002;17:472-7.
50. Ribeiro DA, Carlin V, Fracalossi ACC, Oyama LM. Radiopacifiers do not induce genetic damage in murine fibroblasts: an in vitro study. Int Endod J. 2009;42:987-91.